Brief: Hofseth Biocare: New Study Shows Potential Of Omego As Therapy For Asthma And COPD

Hofseth Biocare ASA

01/09/2020 11:54

Sept 1 (Reuters) - Hofseth Biocare ASA  HOFS.OL :
    * REG-HOFSETH BIOCARE ASA: NEW STUDY HIGHLIGHTS THE
POTENTIAL OF
OMEGO® AS A PROPHYLACTIC THERAPY FOR ASTHMA AND COPD
    * RESULTS OF STUDY SHOW PROPHYLACTIC TREATMENT OF ALLERGIC
HUMAN
PERIPHERAL BLOOD EOSINOPHILS WITH OMEGO MODULATES EOSINOPHIL
EFFECTOR FUNCTION AND INCREASES APOPTOSIS
    * EOSINOPHIL INHIBITION WITH OMEGO® WAS COMPARABLE TO
APOA-IV
(ACTIVE CONTROL) AND MARKEDLY BETTER THAN PROCESSED SALMON OIL
    * KRILL OIL AND STANDARD FISH OIL SHOWED NO TO LOW
EOSINOPHIL
MODULATION
    * NON-OMEGA FRACTION IN OMEGO PROVIDES TARGETED ACTION OF
MODULATING EOSINOPHIL FUNCTION AND THIS FRACTION IS MOSTLY
DESTROYED IN PROCESSED SALMON OIL AND ABSENT IN KRILL OIL AND
STANDARD "18/12" FISH OIL

Source text for Eikon:  ID:nGNE2W6Zl 
Further company coverage:  HOFS.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))